Clinical trial · Interventional
Study on the Use of Lateral Decubitus Position in Left Breast Cancer Patients Undergoing Adjuvant Radiotherapy
A Prospective Study on the Application of Lateral Decubitus Position in Patients With Left Breast Cancer Undergoing Adjuvant Radiotherapy
NCT06902051CI-TRIAL-00089541LDPLBCrecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A Prospective Study on the Application of Lateral Decubitus Position in Patients with Left Breast Cancer Undergoing Adjuvant Radiotherapy
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Lateral Decubitus device | Device | — | UNRESOLVED |
| Lateral Decubitus position | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Lateral Decubitus Position in Patients with Left Breast Ca
- interventionNames
- Device: Lateral Decubitus position
- Device: Lateral Decubitus device
- type
- NO_INTERVENTION
- label
- Prone
Primary outcomes (6)
- measure
- Radiotherapy Planning Dose-Volume Parameter -Volume of 5Gy heart dose
- timeFrame
- From study participation to the completion of the radiotherapy plan up to 2 years
- description
- Volume of 5Gy heart dose
- measure
- Radiotherapy Planning Dose-Volume Parameter -Max dose of LAD
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Voluntary signing of the informed consent form * Female patients aged 18-70 years * Newly diagnosed left-sided breast cancer confirmed by histopathology * No evidence of distant metastasis * Undergoing modified radical mastectomy or breast-conserving surgery * ECOG performance status of 0, 1, or 2 * Tolerance to radiotherapy * Radiation field covering the entire left breast/chest wall ± regional lymphatic drainage area Exclusion Criteria: * Bilateral breast cancer at diagnosis * History of breast reconstruction or implant placement on the affected side * Prior radiotherapy to the chest or supraclavicular region * Patients deemed unsuitable for the study based on the investigator's judgment
References
Publications (0)
Data not yet available
No reference posted for this study.